AstraZeneca (AZN) Financial Statements & Analysis

AstraZeneca (AZN) Income Statement

AstraZeneca reported revenue of $58.74B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 8.6% from $54.07B a year earlier. Net income was $10.22B, up 45.3% year over year, a net margin of 17.4%. Gross margin was 81.9% and operating margin 23.4%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $15.38B, up 3.6% from the same quarter a year earlier.

AstraZeneca Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

AstraZeneca PLC income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	58.74	54.07	45.81	44.35	37.11	29.27	24.50	20.99	23.45
Cost of Revenue	10.75	10.21	8.05	8.64	14.51	7.61	6.77	5.92	6.07
Gross Profit	48.11	43.87	37.54	31.96	22.60	21.66	17.73	15.06	17.38
Operating Expenses
Research & Development	13.85	13.58	10.31	9.67	8.38	6.46	5.35	5.00	5.65
Selling, General & Administrative	20.07	20.22	18.04	17.46	11.36	10.24	9.56	8.32	8.11
Operating Expenses	34.36	33.62	29.35	28.20	19.79	16.69	14.91	13.32	13.76
Operating Income	13.74	10.25	8.19	3.76	2.81	4.97	2.82	1.74	3.62
Other Income/Expense
Interest Income	0.35	0.35	0.33	0.09	0.01	0.04	0.12	0.09	0.07
Interest Expense	-1.69	1.68	-1.22	-0.92	0.76	0.78	0.78	0.70	0.69
Other Income/Expense	-1.34	-4.01	-1.29	-1.26	-3.07	-0.82	-1.26	0.15	-1.30
Income
Income Before Tax	12.40	8.69	6.90	2.50	-0.26	4.15	1.56	1.89	2.32
Income Tax Expense	2.17	1.65	0.94	-0.79	-0.37	0.82	0.32	-0.05	-0.67
Net Income	10.23	7.04	5.96	3.29	0.11	3.39	1.34	2.05	3.13
Net Income - Continuous Operations	10.23	7.04	6.06	3.29	0.11	3.39	1.34	2.05	3.13
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	19.28	15.44	14.28	13.74	4.59	8.04	5.24	5.34	5.64
EBIT	14.29	10.37	9.70	8.81	2.90	-	-	-	-
Depreciation & Amortization	5.52	5.07	4.58	4.93	4.02	3.07	2.80	2.64	2.56
Earnings Per Share
Basic EPS	7.00	5.00	4.00	2.00	-	3.00	1.00	2.00	2.00
Diluted EPS	7.00	5.00	4.00	2.00	-	3.00	1.00	2.00	2.00
Basic Shares Outstanding	1.55	1.55	1.55	1.55	1.42	1.31	1.30	1.27	1.27
Diluted Shares Outstanding	1.56	1.56	1.56	1.56	1.43	1.31	1.30	1.27	1.27

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AstraZeneca Financial Statements

What was AstraZeneca's revenue in fiscal 2025?

AstraZeneca reported revenue of $58.74B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 8.6% from $54.07B a year earlier.

Is AstraZeneca profitable?

Yes. AstraZeneca earned net income of $10.22B in fiscal 2025, a net margin of 17.4%. In fiscal 2024 it earned $7.04B.

What is AstraZeneca's operating margin?

AstraZeneca's operating income was $13.74B on revenue of $58.74B in fiscal 2025, an operating margin of 23.4%, compared with 19.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition